XXE5X5A
Measurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
- Release
- FY 2027
- Effective
Character Breakdown
Each character position in XXE5X5A resolves to one value from the official ICD-10-PCS tables.
- 1. Section X — New Technology
- 2. Body System X — Physiological Systems
- 3. Operation E — Measurement
- 4. Body Part 5 — Circulatory
- 5. Approach X — External
- 6. Device / Substance / Technology 5 — Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability
- 7. Qualifier A — New Technology Group 10
- E · Operation: Measurement
- Determining the level of a physiological or physical function at a point in time
Hierarchy
Where XXE5X5A sits in the official hierarchy. Each level is the code it is classified under.
- XXE Parent New Technology, Physiological Systems, Measurement
- XXE5X5A This code Measurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
Version History
How XXE5X5A appears in each release imported from the official files, newest first.
-
FY 2027 Effective
CurrentMeasurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
-
FY 2026 Effective
UnchangedMeasurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
Related Codes
Other codes under XXE
- XXE0X07 Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7 Billable
- XXE0X1A Measurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10 Billable
- XXE0X48 Measurement of Brain Electrical Activity, Computer-aided Semiologic Analysis, New Technology Group 8 Billable
- XXE2X19 Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9 Billable
- XXE2XHC Measurement of Cardiac Conduction Mechanism, Computer-aided Mapping for Planning, New Technology Group 12 Billable
- XXE3X27 Measurement of Pulmonary Artery Flow, Computer-aided Triage and Notification, New Technology Group 7 Billable
- XXE3X58 Measurement of Coronary Artery Flow, Quantitative Flow Ratio Analysis, New Technology Group 8 Billable
- XXE3X68 Measurement of Coronary Artery Flow, Computer-aided Valve Modeling and Notification, New Technology Group 8 Billable
- XXE5X2A Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10 Billable
- XXE5X38 Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8 Billable
- XXE5X4A Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10 Billable
- XXE5XBB Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11 Billable
- XXE5XV7 Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7 Billable
- XXE5XY9 Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9 Billable
- XXE97U7 Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7 Billable
- XXEZXAB Measurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11 Billable
- XXEZXCB Measurement of Infection, Computer-aided Triage and Notification, New Technology Group 11 Billable
Data Source
Code information on this page is derived from the FY 2027 ICD-10-PCS files published by CMS.
- Release
- FY 2027
- Effective
- Source file
- 2027-icd-10-pcs-order-file-long-abbreviated-titles.zip
Official ICD-10-PCS source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.